임신 준비 영양제 시장(2026-2030년)

The global fertility supplements market is forecasted to grow by USD 878.2 mn during 2025-2030, accelerating at a CAGR of 7.2% during the forecast period. The report on the global fertility supplements market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising integration with clinical ivf protocols and pharmaceutical alignment, technological innovation in bio-availability and personalized nutrigenomics, societal shifts toward delayed parenthood and proactive reproductive health.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global fertility supplements market is segmented as below:

By End-User

• Women
• Men

By Form Factor

• Capsules
• Tablets
• Gummies
• Powders
• Others

By Product Type

• Herbal supplements
• Vitamin-based
• Mineral-based
• Amino acids and antioxidants
• Probiotics

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• APAC
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
• South America
  • Brazil
  • Argentina
  • Chile
• Middle East and Africa
  • UAE
  • South Africa
  • Turkey
• Rest of World (ROW)

This study identifies the rise of male-centric fertility solutions and destigmatization as one of the prime reasons driving the global fertility supplements market growth during the next few years. Also, integration of fertility supplements into corporate wellness and insurance frameworks and expansion of nutrigenomics and ai-driven supplementation will lead to sizable demand in the market.

The report on the global fertility supplements market covers the following areas:

• Global fertility supplements market sizing
• Global fertility supplements market forecast
• Global fertility supplements market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global fertility supplements market vendors that include Active Bio Life Science GmbH, Bionova Lifesciences, Coast Science LLC, Elan Healthcare Inc., Exeltis USA Inc., Fairhaven Health LLC, Fertility Family, Fertility Nutraceuticals LLC, Fertypharm SL, FUJIFILM Irvine Scientific Inc., Lenus Pharma GesmbH, Natural Fertility Shop, Nua Fertility Ltd., Nutra Business LLC, Ocean Healthcare Pvt. Ltd., Orthomol pharmazeutische GmbH, Shivani Scientific Industries, The Bird and Be Co. Inc., TTK Healthcare Ltd., Wild Nutrition Ltd.. Also, the global fertility supplements market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Form Factor
  • Executive Summary - Chart on Market Segmentation by Product Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Fertility Supplements Market 2020 - 2024
  • Historic Market Size - Data Table on Global Fertility Supplements Market 2020 - 2024 ($ million)
• 5.2 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.3 Form Factor segment analysis 2020 - 2024
  • Historic Market Size - Form Factor Segment 2020 - 2024 ($ million)
• 5.4 Product Type segment analysis 2020 - 2024
  • Historic Market Size - Product Type Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI in Global Fertility Supplements Market
• 6.2 Impact of Geopolitical Conflict for Global Fertility Supplements Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by End-user

• 8.1 Market segments
• 8.2 Comparison by End-user
• 8.3 Women - Market size and forecast 2025-2030
• 8.4 Men - Market size and forecast 2025-2030
• 8.5 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

9 Market Segmentation by Form Factor

• 9.1 Market segments
• 9.2 Comparison by Form Factor
• 9.3 Capsules - Market size and forecast 2025-2030
• 9.4 Tablets - Market size and forecast 2025-2030
• 9.5 Gummies - Market size and forecast 2025-2030
• 9.6 Powders - Market size and forecast 2025-2030
• 9.7 Others - Market size and forecast 2025-2030
• 9.8 Market opportunity by Form Factor
  • Market opportunity by Form Factor ($ million)

10 Market Segmentation by Product Type

• 10.1 Market segments
• 10.2 Comparison by Product Type
• 10.3 Herbal supplements - Market size and forecast 2025-2030
• 10.4 Vitamin-based - Market size and forecast 2025-2030
• 10.5 Mineral-based - Market size and forecast 2025-2030
• 10.6 Amino acids and antioxidants - Market size and forecast 2025-2030
• 10.7 Probiotics - Market size and forecast 2025-2030
• 10.8 Market opportunity by Product Type
  • Market opportunity by Product Type ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 APAC - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Australia - Market size and forecast 2025-2030
  • 12.5.6 Indonesia - Market size and forecast 2025-2030
• 12.6 South America - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Argentina - Market size and forecast 2025-2030
  • 12.6.3 Chile - Market size and forecast 2025-2030
• 12.7 Middle East and Africa - Market size and forecast 2025-2030
  • 12.7.1 Saudi Arabia - Market size and forecast 2025-2030
  • 12.7.2 UAE - Market size and forecast 2025-2030
  • 12.7.3 South Africa - Market size and forecast 2025-2030
  • 12.7.4 Israel - Market size and forecast 2025-2030
  • 12.7.5 Turkey - Market size and forecast 2025-2030
• 12.8 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rising integration with clinical IVF protocols and pharmaceutical alignment
  • Technological innovation in bio-availability and personalized nutrigenomics
  • Societal shifts toward delayed parenthood and proactive reproductive health
• 13.2 Market challenges
  • Regulatory stringency and compliance hurdles in North America and Europe
  • Clinical evidence gaps and consumer skepticism globally
  • Supply chain volatility and raw material sourcing challenges
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Rise of male-centric fertility solutions and destigmatization
  • Integration of fertility supplements into corporate wellness and insurance frameworks
  • Expansion of nutrigenomics and AI-driven supplementation

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Active Bio Life Science GmbH
  • Active Bio Life Science GmbH - Overview
  • Active Bio Life Science GmbH - Product / Service
  • Active Bio Life Science GmbH - Key offerings
  • SWOT
• 15.5 Bionova Lifesciences
  • Bionova Lifesciences - Overview
  • Bionova Lifesciences - Product / Service
  • Bionova Lifesciences - Key offerings
  • SWOT
• 15.6 Coast Science LLC
  • Coast Science LLC - Overview
  • Coast Science LLC - Product / Service
  • Coast Science LLC - Key offerings
  • SWOT
• 15.7 Exeltis USA Inc.
  • Exeltis USA Inc. - Overview
  • Exeltis USA Inc. - Product / Service
  • Exeltis USA Inc. - Key offerings
  • SWOT
• 15.8 Fairhaven Health LLC
  • Fairhaven Health LLC - Overview
  • Fairhaven Health LLC - Product / Service
  • Fairhaven Health LLC - Key offerings
  • SWOT
• 15.9 Fertility Family
  • Fertility Family - Overview
  • Fertility Family - Product / Service
  • Fertility Family - Key offerings
  • SWOT
• 15.10 Fertility Nutraceuticals LLC
  • Fertility Nutraceuticals LLC - Overview
  • Fertility Nutraceuticals LLC - Product / Service
  • Fertility Nutraceuticals LLC - Key offerings
  • SWOT
• 15.11 FUJIFILM Irvine Scientific Inc.
  • FUJIFILM Irvine Scientific Inc. - Overview
  • FUJIFILM Irvine Scientific Inc. - Product / Service
  • FUJIFILM Irvine Scientific Inc. - Key offerings
  • SWOT
• 15.12 Lenus Pharma GesmbH
  • Lenus Pharma GesmbH - Overview
  • Lenus Pharma GesmbH - Product / Service
  • Lenus Pharma GesmbH - Key offerings
  • SWOT
• 15.13 Nua Fertility Ltd.
  • Nua Fertility Ltd. - Overview
  • Nua Fertility Ltd. - Product / Service
  • Nua Fertility Ltd. - Key offerings
  • SWOT
• 15.14 Ocean Healthcare Pvt. Ltd.
  • Ocean Healthcare Pvt. Ltd. - Overview
  • Ocean Healthcare Pvt. Ltd. - Product / Service
  • Ocean Healthcare Pvt. Ltd. - Key offerings
  • SWOT
• 15.15 Orthomol pharmazeutische GmbH
  • Orthomol pharmazeutische GmbH - Overview
  • Orthomol pharmazeutische GmbH - Product / Service
  • Orthomol pharmazeutische GmbH - Key offerings
  • SWOT
• 15.16 Shivani Scientific Industries
  • Shivani Scientific Industries - Overview
  • Shivani Scientific Industries - Product / Service
  • Shivani Scientific Industries - Key offerings
  • SWOT
• 15.17 The Bird and Be Co. Inc.
  • The Bird and Be Co. Inc. - Overview
  • The Bird and Be Co. Inc. - Product / Service
  • The Bird and Be Co. Inc. - Key offerings
  • SWOT
• 15.18 TTK Healthcare Ltd.
  • TTK Healthcare Ltd. - Overview
  • TTK Healthcare Ltd. - Business segments
  • TTK Healthcare Ltd. - Key offerings
  • TTK Healthcare Ltd. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations